Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +14.51%
#3 Unit Pump Unit Pump +9.55%
#4 Pump.fun Pump.fun +9.55%
#5 eCash eCash +9.31%
#6 Fake World Assets Fake World Assets +8.82%
#7 OPENLOOT OPENLOOT +8.48%
#8 Meteora Meteora +8.22%
#9 Glidr Glidr +8.12%
#10 Verus Coin Verus Coin +7.75%
Coin of the day
PulseChain PulseChain
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Coeptis Therapeutics Holdings, Inc. Coeptis Therapeutics Holdings, Inc.

Coeptis Therapeutics Holdings, Inc.

COEP
Classificação em ações #28024
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates... Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. The company’s product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze cancer patients if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a chimeric antigen receptor (CAR) therapy for treatment for cancer. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson’s Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Preço da ação
$4.81
Última sincronização: 2026-07-27
Valor de mercado
$29.01M
Variação (1 dia)
-8.56%
Variação (1 ano)
-64.66%
País
US
Negociar Coeptis Therapeutics Holdings, Inc. (COEP)

Categoria

Healthcare
Rácio P/B de Coeptis Therapeutics Holdings, Inc. (COEP)
Rácio P/B em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da Coeptis Therapeutics Holdings, Inc., o rácio P/B atual (TTM) é 0. No final de 2026, o rácio P/B era 0.
Histórico do rácio P/B da Coeptis Therapeutics Holdings, Inc. de 2026 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH